Teva Pharmaceutical prices and manages debt

1 day ago 1
  • Teva Pharmaceutical Industries (NYSE:TEVA) announced the pricing and early acceptance results of its previously announced tender offers to buy for cash the outstanding notes.
  • The disclosed debt tender offers were a strategic move aimed at managing its liabilities, optimizing its

Recommended For You

More Trending News

Read Entire Article